Ann Arbor / Nijmegen / Houston / Manchester / Bethesda / Durham / Birmingham / Camden / Lausanne / /
Company
13Astra Zeneca Pharmaceuticals / Primary Alternative Comments Urinary / Primary Alternative Comments Candidemia Choose / ICD / /
Country
Switzerland / Netherlands / United States / /
Currency
USD / pence / / /
Event
FDA Phase / /
Facility
University of Alabama / University Centre / Cancer Institute / University Blvd / University Medical Center / University of California at Los Angeles Medical Center / After stable / College of Georgia / State University / /
7Medical College of Georgia / 10National Cancer Institute / Infectious Diseases Society of America Peter G. Pappas / 1 Carol A. Kauffman / 2 David Andes / 4 Daniel K. Benjamin / 12Nijmegen University Centre for Infectious Diseases / University of Alabama at Birmingham / University of California at Los Angeles / Expert Panel / 3Wayne State University / Detroit / 5Duke University Medical Center / Standards and Practice Guidelines Committee / Infectious Diseases Society of America / IDSA Board of Directors / IDSA Board / 9Cooper Hospital / Canadian Task Force on the Periodic Health Examination / /
Person
Peter G. Pappas / / /
Position
United Kingdom EXECUTIVE / Executive / liaison advisor / and the Chair / Chair / Fisher / /
Product
itraconazole / AmB suspension / Clotrimazole / Fluconazole / Amphotericin B / nystatin / ABLC / /
ProvinceOrState
Alabama / Michigan / California / Georgia / Texas / New Jersey / Wisconsin / Maryland / North Carolina / /
PublishedMedium
Clinical Infectious Diseases / /
Technology
Chemotherapy / dialysis / transplantation / health care technology / pharmacokinetics / artificial intelligence / /